Colorectal Cancer Screening in North Carolina: Associations with Diabetes Mellitus and Demographic and Health Characteristics

2001 ◽  
Vol 32 (2) ◽  
pp. 163-167 ◽  
Author(s):  
Ronny A. Bell ◽  
Brent J. Shelton ◽  
Electra D. Paskett
Keyword(s):  
Diabetes Mellitus ◽  
Colorectal Cancer ◽  
North Carolina ◽  
Cancer Screening ◽  
Colorectal Cancer Screening

“Fault-line of an Earthquake”: A Qualitative Examination of Barriers and Facilitators to Colorectal Cancer Screening in Rural, Eastern North Carolina

2012 ◽  
Vol 29 (1) ◽  
pp. 78-87 ◽  
Author(s):  
Stephanie B. Jilcott Pitts ◽  
C. Suzanne Lea ◽  
Carrie L. May ◽  
Chelsea Stowe ◽  
Dana J. Hamill ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
North Carolina ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Barriers And Facilitators ◽  
Fault Line ◽  
Eastern North Carolina

scholarly journals Trends in Up-to-Date Status in Colorectal Cancer Screening, North Carolina, 1998-2002

2005 ◽  
Vol 66 (6) ◽  
pp. 420-426
Author(s):  
Jane A. Kim ◽  
Deborah Porterfield ◽  
Ziya Gizlice
Keyword(s):  
Colorectal Cancer ◽  
North Carolina ◽  
Cancer Screening ◽  
Colorectal Cancer Screening

scholarly journals Screening Criteria for Colorectal Cancer for Patients with Type II Diabetes Mellitus

2020 ◽  
Vol 27 (3) ◽  
pp. 195-207
Author(s):  
Alexandra AGACHE ◽  
Sabin BOTEA ◽  
Petronel MUSTATEA ◽  
Florin BOBIRCA
Keyword(s):  
Diabetes Mellitus ◽  
Colorectal Cancer ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
High Morbidity ◽  
Type Ii ◽  
Precursor Lesions ◽  
Antidiabetic Treatment

Colorectal cancer and diabetes mellitus represent a major public health issue, fi rst, by the number of new cases which are at an alarming rate. Secondly, by the negative effect over the quality of life, socio-economic status and lifespan, representing high morbidity and mortality causes. Diabetes Mellitus is the disease of the century with a global prevalence (standardised-age) which doubled since 1980, rising from 4.7% to 8.5% in adult population. In 2012, the estimated number of fatalities caused by diabetes mellitus and other related complications were at 3.7 million, out of which 43% were patients under the age of 70. Neoplasia represents the second cause of death, after cardiovascular disease. Colorectal cancer (CRC) ranks the 3rd regarding the global neoplasia incidence (10.2%) and the second regarding the mortality (9.5% of all cancer deaths). Colorectal cancer screening refers to the periodic evaluation of asymptomatic patients at risk of developing this neoplasia. Colorectal cancer has a number of peculiarities that make it ideal for screening. Since the end of the 19th century, the suspicion has been raised that diabetes mellitus has been involved, through directly etiological mechanisms, in carcinogenesis (breast, endometrium, colorectal, pancreas, liver, non-Hodgkin lymphoma). At the moment, there is already a consensus in the literature on the role of diabetes as an independent risk factor for colorectal cancer. However, despite the existence of numerous experimental evidence, epidemiological studies and meta-analyses, there is currently no adaptation of colorectal cancer screening for these patients. Material and method: Prospective case-control study conducted over a 2-year period including a number of 442 patients presented at „Dr. I Cantacuzino” Clinical Hospital, asymptomatic, who underwent lower digestive endoscopies in order to assess and defi ne using anamnestic, clinical and paraclinical criteria, the profi le of the patient with type II diabetes mellitus that should be given an endoscopic examination because diagnosing precursor lesions or even CRC is likely probable. Results: In the analyzed group, statistically signifi cant correlations (p<0.05) were recorded between positive colonoscopy results (defi ned as precursor lesions – polyps- or tumors) and certain clinical characteristics (age, sex, BMI, duration of diabetes, type of antidiabetic treatment) and also paraclinical (reactive C protein and glycated hemoglobin). Conclusions: Criteria of patients with type II diabetes who have the maximum probability of developing colorectal cancer have been outlined. Thus this patient is more likely male, with a BMI > 25, aged over 60 years, with an unbalanced diabetes mellitus counted by HbA1c > 7 mg/dL, with over 5 years of diabetes evolution, in treatment with insulin most likely or combined insulin with oral antidiabetics and with an inflammatory biological profi le expressed by PCR> 2 mg/dL threshold values.

Tu1185 Should Diabetes Mellitus Be an Indication for Earlier Colorectal Cancer Screening?

2012 ◽  
Vol 142 (5) ◽  
pp. S-769 ◽  
Author(s):  
Hongha T. Vu ◽  
Nneka Ufere ◽  
Yan Yan ◽  
Jean S. Wang ◽  
Dayna S. Early ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Colorectal Cancer ◽  
Cancer Screening ◽  
Colorectal Cancer Screening

scholarly journals Race and Colorectal Cancer Screening: A Population-based Study in North Carolina

2004 ◽  
Vol 65 (1) ◽  
pp. 12-15
Author(s):  
Deborah A. Fisher ◽  
Karen Dougherty ◽  
Christopher Martin ◽  
Joseph Galanko ◽  
Dawn Provenzale ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
North Carolina ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Population Based ◽  
Population Based Study

scholarly journals Cost-Effectiveness Analysis of Four Simulated Colorectal Cancer Screening Interventions, North Carolina

2017 ◽  
Vol 14 ◽  
Author(s):  
Kristen Hassmiller Lich ◽  
David A. Cornejo ◽  
Maria E. Mayorga ◽  
Michael Pignone ◽  
Florence K.L. Tangka ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
North Carolina ◽  
Cost Effectiveness ◽  
Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document